Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

Plasma Neurofilament Analysis in VITALITY-ALS

Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success

Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial

Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness

Tirasemtiv Enhances Submaximal Muscle Tension in an Acta1:p.Asp286Gly Mouse Model of Nemaline Myopathy

Feasibility Assessment of Using the MiToS Staging System for Conducting Economic Evaluation in Amyotrophic Lateral Sclerosis

Time From Amyotrophic Lateral Sclerosis Symptom Onset to Key Disease Milestones: Analysis of Data From a Multinational Cross-Sectional Survey

Site and Participant Perspectives on Participating in an ALS Trial Designed to Reduce Burden: COURAGE-ALS